Carregant...
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX
Here, we wish to propose a new systematic approach to cancer therapy, based on the targeting of mitochondrial metabolism, especially in cancer stem cells (CSCs). In the future, we envision that anti-mitochondrial therapy would ultimately be practiced as an add-on to more conventional therapy, largel...
Guardat en:
| Publicat a: | Cell Cycle |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226227/ https://ncbi.nlm.nih.gov/pubmed/30257595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1515551 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|